Nihon Naika Gakkai Zasshi 2011-10-10

[Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 5. Leflunomide and mizoribine].

Tetsuji Sawada

Index: Nippon. Naika Gakkai Zasshi. 100(10) , 2929-35, (2011)

Full Text: HTML

Structure	Name/CAS No.	Molecular Formula	Articles
	Leflunomide CAS:75706-12-6	C₁₂H₉F₃N₂O₂
	Mizoribine CAS:50924-49-7	C₉H₁₃N₃O₆

Gingival pain: an unusual side effect of ziprasidone.
2013-01-01
[BMJ Case Rep. 2013 , doi:10.1136/bcr-2012-007577, (2013)]

An in vivo antilymphatic screen in zebrafish identifies nove...
2014-10-01
[Mol. Cancer Ther. 13(10) , 2450-62, (2014)]

SND-117, a sinomenine bivalent alleviates type II collagen-i...
2015-06-01
[Int. Immunopharmacol. 26 , 423-31, (2015)]

miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 a...
2015-01-01
[Nat. Commun. 6 , 8523, (2015)]

Methotrexate in combination with other DMARDs is not superio...
2015-01-01
[Ann. Rheum. Dis. 74(1) , 27-34, (2015)]